FDA Inspection
Teva Womens Health, LLCTeva Womens Health, LLC – FDA Inspection, Feb 8, 2019
Record Details
This FDA Inspection record concerns Teva Womens Health, LLC, with an inspection on February 8, 2019, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · 9e62b96a-2747-43b9-b23a-3f50b0a5a5ad
Inspection Facts
- Inspection number
- 1078871
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.160(b)(3)Acceptance of drug products
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.165(f)Failing drug products not rejected
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Teva Womens Health, LLC
12| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2026 | Not classified | Cincinnati District Office | Drug Quality Assurance |
| March 26, 2025 | Not classified | Cincinnati District Office | |
| April 7, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 8, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 26, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Womens Health, LLC
- FDA Inspection 1308790 - 2026-03-20
- FDA Inspection 1265070 - 2025-03-26
- FDA Inspection 1205874 - 2023-04-07
- FDA Inspection 1116385 - 2020-01-08
- FDA Inspection 1038720 - 2018-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.